Anti-HCV-core specific IgM in porphyria cutanea tarda

Luciana D'Alessandro Gandolfo, Franco Ameglio, Gianfranco Biolcati, Fulvia Pimpinelli, Elisabetta Trento, Marisa Galante, Armande Nardi, Giancarlo Topi

Research output: Contribution to journalArticle

Abstract

Aim: Analysis of the prevalence of serum IgM antibodies directed against the HCV-core antigen (HCV-IgM) in patients with Porphyria cutanea tarda (PCT), taking into account the hepatic histological picture, liver biochemical markers and the PCT biochemical indices. Background: Hepatic damage, especially that due to HCV infection, has been previously reported as a PCT trigger. HCV-IgM reactivity, a marker of chronic HCV hepatitis, suggested to be related to active virus replication could also be related to the PCT clinical course. Methods: Blood samples of 97 patients, previously analyzed for a panel of clinical, histological and laboratory variables, followed in our Centre for Porphyria, stored at -80°C, were available to be retrospectively assayed for anti-HCV-core IgM (HCV-IgM, ELISA). Results: 61% HCV-IgM positivity was found, with no apparent significant relationship with the respective histological hepatitis classification, PCT remission phase, and PCT familiarity, when evaluated on overall patients. The levels of HCV-IgM presented a peculiar behaviour when correlated to the serum AST values. In fact, there was a significant positive correlation in those with HCV-IgM <4 and a not significant, inverse correlation in the remaining group. These two groups showed other differences: the HCV-IgM levels were correlated to histology, PCT remission and to the markers of liver disease (such as AST and ALT) only in the first group. Conclusion: a relationship between IgM response, PCT activity and the underlying liver disease is suggested.

Original languageEnglish
Pages (from-to)226-231
Number of pages6
JournalJournal of the European Academy of Dermatology and Venereology
Volume6
Issue number3
DOIs
Publication statusPublished - 1996

Fingerprint

Porphyria Cutanea Tarda
Immunoglobulin M
Liver Diseases
Liver
Porphyrias
Chronic Hepatitis
Virus Replication
Serum
Hepatitis
Histology
Biomarkers
Enzyme-Linked Immunosorbent Assay

Keywords

  • Anti-HCV-Core-IgM
  • Chronic hepatitis
  • PCT

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Anti-HCV-core specific IgM in porphyria cutanea tarda. / D'Alessandro Gandolfo, Luciana; Ameglio, Franco; Biolcati, Gianfranco; Pimpinelli, Fulvia; Trento, Elisabetta; Galante, Marisa; Nardi, Armande; Topi, Giancarlo.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 6, No. 3, 1996, p. 226-231.

Research output: Contribution to journalArticle

D'Alessandro Gandolfo, Luciana ; Ameglio, Franco ; Biolcati, Gianfranco ; Pimpinelli, Fulvia ; Trento, Elisabetta ; Galante, Marisa ; Nardi, Armande ; Topi, Giancarlo. / Anti-HCV-core specific IgM in porphyria cutanea tarda. In: Journal of the European Academy of Dermatology and Venereology. 1996 ; Vol. 6, No. 3. pp. 226-231.
@article{9392059f25384932ab7c1c04db1a3fad,
title = "Anti-HCV-core specific IgM in porphyria cutanea tarda",
abstract = "Aim: Analysis of the prevalence of serum IgM antibodies directed against the HCV-core antigen (HCV-IgM) in patients with Porphyria cutanea tarda (PCT), taking into account the hepatic histological picture, liver biochemical markers and the PCT biochemical indices. Background: Hepatic damage, especially that due to HCV infection, has been previously reported as a PCT trigger. HCV-IgM reactivity, a marker of chronic HCV hepatitis, suggested to be related to active virus replication could also be related to the PCT clinical course. Methods: Blood samples of 97 patients, previously analyzed for a panel of clinical, histological and laboratory variables, followed in our Centre for Porphyria, stored at -80°C, were available to be retrospectively assayed for anti-HCV-core IgM (HCV-IgM, ELISA). Results: 61{\%} HCV-IgM positivity was found, with no apparent significant relationship with the respective histological hepatitis classification, PCT remission phase, and PCT familiarity, when evaluated on overall patients. The levels of HCV-IgM presented a peculiar behaviour when correlated to the serum AST values. In fact, there was a significant positive correlation in those with HCV-IgM <4 and a not significant, inverse correlation in the remaining group. These two groups showed other differences: the HCV-IgM levels were correlated to histology, PCT remission and to the markers of liver disease (such as AST and ALT) only in the first group. Conclusion: a relationship between IgM response, PCT activity and the underlying liver disease is suggested.",
keywords = "Anti-HCV-Core-IgM, Chronic hepatitis, PCT",
author = "{D'Alessandro Gandolfo}, Luciana and Franco Ameglio and Gianfranco Biolcati and Fulvia Pimpinelli and Elisabetta Trento and Marisa Galante and Armande Nardi and Giancarlo Topi",
year = "1996",
doi = "10.1016/0926-9959(95)00164-6",
language = "English",
volume = "6",
pages = "226--231",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "wiley",
number = "3",

}

TY - JOUR

T1 - Anti-HCV-core specific IgM in porphyria cutanea tarda

AU - D'Alessandro Gandolfo, Luciana

AU - Ameglio, Franco

AU - Biolcati, Gianfranco

AU - Pimpinelli, Fulvia

AU - Trento, Elisabetta

AU - Galante, Marisa

AU - Nardi, Armande

AU - Topi, Giancarlo

PY - 1996

Y1 - 1996

N2 - Aim: Analysis of the prevalence of serum IgM antibodies directed against the HCV-core antigen (HCV-IgM) in patients with Porphyria cutanea tarda (PCT), taking into account the hepatic histological picture, liver biochemical markers and the PCT biochemical indices. Background: Hepatic damage, especially that due to HCV infection, has been previously reported as a PCT trigger. HCV-IgM reactivity, a marker of chronic HCV hepatitis, suggested to be related to active virus replication could also be related to the PCT clinical course. Methods: Blood samples of 97 patients, previously analyzed for a panel of clinical, histological and laboratory variables, followed in our Centre for Porphyria, stored at -80°C, were available to be retrospectively assayed for anti-HCV-core IgM (HCV-IgM, ELISA). Results: 61% HCV-IgM positivity was found, with no apparent significant relationship with the respective histological hepatitis classification, PCT remission phase, and PCT familiarity, when evaluated on overall patients. The levels of HCV-IgM presented a peculiar behaviour when correlated to the serum AST values. In fact, there was a significant positive correlation in those with HCV-IgM <4 and a not significant, inverse correlation in the remaining group. These two groups showed other differences: the HCV-IgM levels were correlated to histology, PCT remission and to the markers of liver disease (such as AST and ALT) only in the first group. Conclusion: a relationship between IgM response, PCT activity and the underlying liver disease is suggested.

AB - Aim: Analysis of the prevalence of serum IgM antibodies directed against the HCV-core antigen (HCV-IgM) in patients with Porphyria cutanea tarda (PCT), taking into account the hepatic histological picture, liver biochemical markers and the PCT biochemical indices. Background: Hepatic damage, especially that due to HCV infection, has been previously reported as a PCT trigger. HCV-IgM reactivity, a marker of chronic HCV hepatitis, suggested to be related to active virus replication could also be related to the PCT clinical course. Methods: Blood samples of 97 patients, previously analyzed for a panel of clinical, histological and laboratory variables, followed in our Centre for Porphyria, stored at -80°C, were available to be retrospectively assayed for anti-HCV-core IgM (HCV-IgM, ELISA). Results: 61% HCV-IgM positivity was found, with no apparent significant relationship with the respective histological hepatitis classification, PCT remission phase, and PCT familiarity, when evaluated on overall patients. The levels of HCV-IgM presented a peculiar behaviour when correlated to the serum AST values. In fact, there was a significant positive correlation in those with HCV-IgM <4 and a not significant, inverse correlation in the remaining group. These two groups showed other differences: the HCV-IgM levels were correlated to histology, PCT remission and to the markers of liver disease (such as AST and ALT) only in the first group. Conclusion: a relationship between IgM response, PCT activity and the underlying liver disease is suggested.

KW - Anti-HCV-Core-IgM

KW - Chronic hepatitis

KW - PCT

UR - http://www.scopus.com/inward/record.url?scp=8944231157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8944231157&partnerID=8YFLogxK

U2 - 10.1016/0926-9959(95)00164-6

DO - 10.1016/0926-9959(95)00164-6

M3 - Article

VL - 6

SP - 226

EP - 231

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 3

ER -